Pfizer's quit-smoking drug not linked to depression or heart risks

LONDON (Reuters) - Pfizer's stop-smoking drug Chantix does not raise risks of heart attack or depression, contrary to previous reports, and should be recommended to more smokers wanting to quit, scientists said on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news